NCT01078558View on ClinicalTrials.gov

A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )

CompletedOBSERVATIONAL
Enrollment

5,940

Participants

Timeline

Start Date

May 13, 2004

Primary Completion Date

January 11, 2018

Study Completion Date

January 11, 2018

Conditions
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
Sponsors

Collaborators (1)

Veeda Clinical Research
All Listed Sponsors
collaborator

Veeda Clinical Research

INDUSTRY

lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01078558 - A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) | Biotech Hunter | Biotech Hunter